Dosage and administration
Adults and children over 12 years age: 1 tablet daily preferably with a meal or as directed by a doctor. Children under 12 years of age: consult a doctor. Do not exceed recommended dosage.
Adults and children over 12 years age: 1 tablet daily preferably with a meal or as directed by a doctor. Children under 12 years of age: consult a doctor. Do not exceed recommended dosage.
Serving Size 1 Tablet
Servings Per Container 1000
| Amount Per Serving | % Daily Value | |
| Iron (as ferrous sulfate) | 65 mg | 361% |
Other ingredients: croscarmellose sodium, dicalcium phosphate, FD&C blue #1, FD&C yellow #6, hypromellose, magnesium stearate, microcrystalline cellulose, mineral oil, polyethylene glycol, sodium starch glycolate, stearic acid, talc, titanium dioxide, triacetin
Formula: Each tablet contains 202 mg of dried ferrous sulfate USP (65 mg of elemental iron), equivalent to 325 mg of ferrous sulfate USP.
Adults and children over 12 years age: 1 tablet daily preferably with a meal or as directed by a doctor. Children under 12 years of age: consult a doctor. Do not exceed recommended dosage.
Since oral iron products interfere with absorption of certain antibiotics; these products should not be taken within two hours of each other. if you are pregnant, nursing or taking any medications, consult your doctior befoe use. Discontinue use and consult your doctor if any adverse reactions occur.
| WARNING: Accidental overdose of iron-containing products is a leading cause of fatal poisoning in children under 6. Keep this product out of the reach of children. In case of accidental overdose, call a doctor or Poison Control Center immediately. |
Store at room temperature. Keep tightly closed in a cool dry place.
Questions or comments? (866) 562-2756 Mon-Fri 8 AM to 4 PM EST
PHARBEST
Manufactured in the USA
*Compare to the active ingredient in Feosol®
Ferrous
Sulfate
Iron Supplement
325 mg
1000 TABLETS
| RxCUI | RxNorm string | TTY | SPL version |
|---|---|---|---|
| 310325 | ferrous sulfate 325 MG (iron 65 MG) Oral Tablet | PSN | 1 |
| 310325 | ferrous sulfate 325 MG Oral Tablet | SCD | 1 |
| 310325 | ferrous sulfate 324 MG (iron 65 MG) Oral Tablet | SY | 1 |
| 310325 | ferrous sulfate 325 MG (iron 65 MG) Oral Tablet | SY | 1 |
| 310325 | FESO4 325 MG Oral Tablet | SY | 1 |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 16103-382-08 | Ferrous Sulfate | 100 in 1 BOTTLE, PLASTIC | TABLET, FILM COATED | 100 | 1 | |
| 16103-382-11 | Ferrous Sulfate | 1000 in 1 BOTTLE, PLASTIC | TABLET, FILM COATED | 1000 | 1 |
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 16103-382-08 | EA - Each | 16103-382 | 89b098e8-9d6f-4fe4-bfd1-5b2e49c1466a | 1 | 2021-04-08 |
| 16103-382-11 | EA - Each | 16103-382 | 65f33516-e3cd-45a4-aaec-a5c7e1630c93 | 1 | 2021-04-08 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 16103-382 | 16103-382-08, 16103-382-11 |
Every source-derived ingredient row is available through these pages.
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| FERRUM SULPHURICUM | FERROUS SULFATE | Boiron | 3a749d62-0e20-0c15-e063-6394a90ac1a8 | 2025-07-21 | FERROUS SULFATE | |
| FERROUS SULFATE | FERROUS SULFATE | Richmond Pharmaceuticals, Inc. | 58dd4f30-980b-44bc-9f8e-8d4626854b91 | 2024-12-26 | Warnings | FERROUS SULFATE FERROUS SULFATE |
| Ferrous Sulfate | FERROUS SULFATE | Richmond Pharmaceuticals Inc. | 5514d582-19b5-4f1e-b794-f790afb8211c | 2024-12-26 | Boxed warning, Warnings | Ferrous Sulfate FERROUS SULFATE |
| Ferrum sulphuricum | FERROUS SULFATE | Boiron | 7a4087d8-d054-bbdc-e053-2991aa0ae8cf | 2023-11-13 | FERROUS SULFATE |
Adverse event summaries are temporarily unavailable. Other product information remains available.